Renin-angiotensin system gene polymorphisms: Potential mechanisms for their association with cardiovascular diseases

European Journal of Pharmacology

Volumn 410, Issue 2-3, 2000, Pages 303-316

  Danser, A H Jan ^a   Schunkert, Heribert ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Angiotensin; Angiotensin AT1 receptor; Angiotensin converting enzyme; Angiotensinogen; Polymorphism; Renin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ARTICLE; CARDIOVASCULAR DISEASE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0034723042     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00823-2     Document Type: Article

References (83)

1. Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension
2. Regional angiotensin II production in essential hypertension and renal artery stenosis
3. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction
4. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension
5. ACE insertion/deletion polymorphism affects bradykinin metabolism
6. The deletion polymorphism of the angiotensin-converting enzyme gene is related to phenotypic differences in human arteries
7. Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy
8. Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes
9. Angiotensin I-converting enzyme genotype influences arterial response to injury in normotensive rats
10. Metabolism of angiotensin I by different tissues in the intact animal
11. Cardiac renin and angiotensins: Uptake from plasma versus in situ synthesis
12. Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism
13. Prorenin, renin, angiotensinogen and ACE in normal and failing human hearts: Evidence for renin-binding
14. Angiotensinogen (M235T) and angiotensin - Converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels
15. Determinants of interindividual renin and prorenin variation. Evidence for a sexual dimorphism of (pro)renin in humans
16. Angiotensin I-to-II conversion in the human forearm and leg. Effect of the ACE gene I/D polymorphism
17. Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I
18. Prediction of patient response to antihypertensive drugs using gene polymorphisms: Investigation of renin-angiotensin system genes
19. Freely associating
20. Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians
21. Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males
22. 232 is required for angiotensinogen-pro major basic protein complex formation
23. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism
24. Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian study group of the effects of enalapril treatment in proteinuric renal disease
25. Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy
26. Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro
27. The deletion genotype of the angiotensin I-converting enzyme is associated with an increased vascular reactivity in vivo and in vitro
28. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: The Suita Study
29. 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II
30. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition
31. Abnormal renal function, sodium-volume homeostasis, and renin system behavior in normal-renin essential hypertension
32. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
33. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity
34. A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system
35. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro
36. Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy
37. Molecular basis of human hypertension: Role of angiotensinogen
38. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators
39. Association between angiotensin-converting enzyme gene polymorphism and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors
40. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects
41. Vasoconstriction by in situ formed angiotensin II: Role of ACE and chymase
42. Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II
43. Renal hemodynamic changes induced by captopril and angiotensin-converting enzyme gene polymorphism
44. Renal ACE immunohistochemical localization in NIDDM patients with nephropathy
45. Contribution of angiotensin I-converting enzyme gene polymorphism and angiotensinogen polymorphism to blood pressure regulation in essential hypertension
46. Angiotensinogen T235 expression is elevated in decidual spiral arteries
47. Association of angiotensin I-converting enzyme gene polymorphism with susceptibility to antiproteinuric effect of angiotensin I-converting enzyme inhibitors in patients with proteinuria
48. Local angiotensin II generation in the rat heart. Role of renin uptake
49. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight
50. Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension
51. Angiotensin-converting enzyme gene and renal disease
52. Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study
53. Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype
54. 1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy
55. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure
56. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population
57. Characterization of the binding of the RNA-binding protein AUF1 to the human AT(1) receptor mRNA
58. Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilatation after anterior myocardial infarction
59. A 40-fold increase in cardiac angiotensin converting enzyme activity fails to increase local angiotensin II concentrations
60. Insertion-deletion polymorphism of the ACE gene modulates reversibility of endothelial dysfunction with ACE inhibition
61. Sequence variation in the human angiotensin converting enzyme
62. An insertion/deletion polymorphism of the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels
63. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction
64. Functional importance of ACE-dependent in-situ angiotensin II generation in the human forearm
65. Relationship between the angiotensin converting enzyme gene polymorphism and the effect of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies
66. Cardiac interstitial fluid levels of angiotensin I and II in the pig
67. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease
68. Controversial association of left ventricular hypertrophy and the ACE I/D polymorphism- is the mist clearing up?
69. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. Effects on coronary resistance, contractility, and relaxation
70. Distribution and functional significance of angiotensin converting enzyme in hypertrophied rat hearts
71. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy
72. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population-based cohort
73. Human vascular reactivity and polymorphisms of the angiotensin-converting enzyme and the angiotensin type 1 receptor genes
74. Relation between changes in blood pressure and serum ACE activity after a single dose of enalapril and ACE genotype in healthy subjects
75. Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme
76. ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans
77. Angiotensin II-forming pathways in normal and failing human hearts
78. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibitors: Role of sodium status
79. The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm
80. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries
81. Prediction of coronary heart disease using risk factor categories
82. Functional significance of ACE I/D locus for controlling the ACE gene
83. Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene